Page last updated: 2024-08-21

megestrol acetate and Carcinoma, Ductal, Breast

megestrol acetate has been researched along with Carcinoma, Ductal, Breast in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carli, AF; Correale, P; Francini, E; Francini, G; Guarnieri, A; Licchetta, A; Magliocca, A; Migali, C; Pascucci, A; Piccolomini, A; Remondo, C; Savelli, V1
Karakuzu, A; Koc, M; Ozdemir, S1
Carnero López, B; Carrasco Alvarez, JA; Fernández Pérez, I; Gentil González, M; González Villarroel, P; Páramo, C; Vázquez Tuñas, ML1
Andersen, J; Cold, S; Ejlertsen, B; Ewertz, M; Jacobsen, EH; Jensen, D; Kamby, C; Møller, KA; Møller, S; Philip, P1
Altaras, M; Beyth, Y; Cohen, I; Cordoba, M; Shulman, A; Tepper, R1

Trials

2 trial(s) available for megestrol acetate and Carcinoma, Ductal, Breast

ArticleYear
Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:3

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Megestrol Acetate; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome

2010
Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C).
    Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Mastectomy, Segmental; Megestrol Acetate; Middle Aged; Postmenopause; Risk Factors; Survival Rate; Tamoxifen; Treatment Outcome

2008

Other Studies

3 other study(ies) available for megestrol acetate and Carcinoma, Ductal, Breast

ArticleYear
Multiple cutaneous metastases from male breast carcinoma.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Epirubicin; Fatal Outcome; Fluorouracil; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mastectomy, Radical; Megestrol Acetate; Middle Aged; Paclitaxel; Palliative Care; Skin Neoplasms

2006
Megestrol acetate-induced adrenal insufficiency.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:4

    Topics: Adrenal Insufficiency; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Megestrol Acetate; Pericardial Effusion

2008
Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate.
    Gynecologic and obstetric investigation, 1994, Volume: 38, Issue:2

    Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Endometrium; Estrogens; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen

1994